Global Lysosomal Storage Disease (LSD) Market Research Report 2024(Status and Outlook)

Global Lysosomal Storage Disease (LSD) Market Research Report 2024(Status and Outlook)



Report Overview:

Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.

The Global Lysosomal Storage Disease (LSD) Market Size was estimated at USD 5592.92 million in 2023 and is projected to reach USD 7452.32 million by 2029, exhibiting a CAGR of 4.90% during the forecast period.

This report provides a deep insight into the global Lysosomal Storage Disease (LSD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lysosomal Storage Disease (LSD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lysosomal Storage Disease (LSD) market in any manner.

Global Lysosomal Storage Disease (LSD) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Actelion Pharmaceuticals

Amicus Therapeutics

Arena Pharmaceuticals

Astellas Pharma

Astrazeneca

Biomarin Pharmaceutical

Eli Lilly

Lexicon Pharmaceuticals

Novo Nordisk

Merck

Market Segmentation (by Type)

Lipid Metabolism Disorder

Glycoprotein Metabolism Disorder

Market Segmentation (by Application)

Hospitals

Clinics

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Lysosomal Storage Disease (LSD) Market
  • Overview of the regional outlook of the Lysosomal Storage Disease (LSD) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lysosomal Storage Disease (LSD) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lysosomal Storage Disease (LSD)
1.2 Key Market Segments
1.2.1 Lysosomal Storage Disease (LSD) Segment by Type
1.2.2 Lysosomal Storage Disease (LSD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lysosomal Storage Disease (LSD) Market Overview
2.1 Global Market Overview
2.1.1 Global Lysosomal Storage Disease (LSD) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lysosomal Storage Disease (LSD) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lysosomal Storage Disease (LSD) Market Competitive Landscape
3.1 Global Lysosomal Storage Disease (LSD) Sales by Manufacturers (2019-2024)
3.2 Global Lysosomal Storage Disease (LSD) Revenue Market Share by Manufacturers (2019-2024)
3.3 Lysosomal Storage Disease (LSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lysosomal Storage Disease (LSD) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lysosomal Storage Disease (LSD) Sales Sites, Area Served, Product Type
3.6 Lysosomal Storage Disease (LSD) Market Competitive Situation and Trends
3.6.1 Lysosomal Storage Disease (LSD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lysosomal Storage Disease (LSD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Lysosomal Storage Disease (LSD) Industry Chain Analysis
4.1 Lysosomal Storage Disease (LSD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Lysosomal Storage Disease (LSD) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Lysosomal Storage Disease (LSD) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lysosomal Storage Disease (LSD) Sales Market Share by Type (2019-2024)
6.3 Global Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2019-2024)
6.4 Global Lysosomal Storage Disease (LSD) Price by Type (2019-2024)
7 Lysosomal Storage Disease (LSD) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lysosomal Storage Disease (LSD) Market Sales by Application (2019-2024)
7.3 Global Lysosomal Storage Disease (LSD) Market Size (M USD) by Application (2019-2024)
7.4 Global Lysosomal Storage Disease (LSD) Sales Growth Rate by Application (2019-2024)
8 Lysosomal Storage Disease (LSD) Market Segmentation by Region
8.1 Global Lysosomal Storage Disease (LSD) Sales by Region
8.1.1 Global Lysosomal Storage Disease (LSD) Sales by Region
8.1.2 Global Lysosomal Storage Disease (LSD) Sales Market Share by Region
8.2 North America
8.2.1 North America Lysosomal Storage Disease (LSD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lysosomal Storage Disease (LSD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lysosomal Storage Disease (LSD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lysosomal Storage Disease (LSD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lysosomal Storage Disease (LSD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Actelion Pharmaceuticals
9.1.1 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Basic Information
9.1.2 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product Overview
9.1.3 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product Market Performance
9.1.4 Actelion Pharmaceuticals Business Overview
9.1.5 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) SWOT Analysis
9.1.6 Actelion Pharmaceuticals Recent Developments
9.2 Amicus Therapeutics
9.2.1 Amicus Therapeutics Lysosomal Storage Disease (LSD) Basic Information
9.2.2 Amicus Therapeutics Lysosomal Storage Disease (LSD) Product Overview
9.2.3 Amicus Therapeutics Lysosomal Storage Disease (LSD) Product Market Performance
9.2.4 Amicus Therapeutics Business Overview
9.2.5 Amicus Therapeutics Lysosomal Storage Disease (LSD) SWOT Analysis
9.2.6 Amicus Therapeutics Recent Developments
9.3 Arena Pharmaceuticals
9.3.1 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Basic Information
9.3.2 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product Overview
9.3.3 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product Market Performance
9.3.4 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) SWOT Analysis
9.3.5 Arena Pharmaceuticals Business Overview
9.3.6 Arena Pharmaceuticals Recent Developments
9.4 Astellas Pharma
9.4.1 Astellas Pharma Lysosomal Storage Disease (LSD) Basic Information
9.4.2 Astellas Pharma Lysosomal Storage Disease (LSD) Product Overview
9.4.3 Astellas Pharma Lysosomal Storage Disease (LSD) Product Market Performance
9.4.4 Astellas Pharma Business Overview
9.4.5 Astellas Pharma Recent Developments
9.5 Astrazeneca
9.5.1 Astrazeneca Lysosomal Storage Disease (LSD) Basic Information
9.5.2 Astrazeneca Lysosomal Storage Disease (LSD) Product Overview
9.5.3 Astrazeneca Lysosomal Storage Disease (LSD) Product Market Performance
9.5.4 Astrazeneca Business Overview
9.5.5 Astrazeneca Recent Developments
9.6 Biomarin Pharmaceutical
9.6.1 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Basic Information
9.6.2 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product Overview
9.6.3 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product Market Performance
9.6.4 Biomarin Pharmaceutical Business Overview
9.6.5 Biomarin Pharmaceutical Recent Developments
9.7 Eli Lilly
9.7.1 Eli Lilly Lysosomal Storage Disease (LSD) Basic Information
9.7.2 Eli Lilly Lysosomal Storage Disease (LSD) Product Overview
9.7.3 Eli Lilly Lysosomal Storage Disease (LSD) Product Market Performance
9.7.4 Eli Lilly Business Overview
9.7.5 Eli Lilly Recent Developments
9.8 Lexicon Pharmaceuticals
9.8.1 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Basic Information
9.8.2 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product Overview
9.8.3 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product Market Performance
9.8.4 Lexicon Pharmaceuticals Business Overview
9.8.5 Lexicon Pharmaceuticals Recent Developments
9.9 Novo Nordisk
9.9.1 Novo Nordisk Lysosomal Storage Disease (LSD) Basic Information
9.9.2 Novo Nordisk Lysosomal Storage Disease (LSD) Product Overview
9.9.3 Novo Nordisk Lysosomal Storage Disease (LSD) Product Market Performance
9.9.4 Novo Nordisk Business Overview
9.9.5 Novo Nordisk Recent Developments
9.10 Merck
9.10.1 Merck Lysosomal Storage Disease (LSD) Basic Information
9.10.2 Merck Lysosomal Storage Disease (LSD) Product Overview
9.10.3 Merck Lysosomal Storage Disease (LSD) Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
10 Lysosomal Storage Disease (LSD) Market Forecast by Region
10.1 Global Lysosomal Storage Disease (LSD) Market Size Forecast
10.2 Global Lysosomal Storage Disease (LSD) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lysosomal Storage Disease (LSD) Market Size Forecast by Country
10.2.3 Asia Pacific Lysosomal Storage Disease (LSD) Market Size Forecast by Region
10.2.4 South America Lysosomal Storage Disease (LSD) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lysosomal Storage Disease (LSD) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Lysosomal Storage Disease (LSD) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lysosomal Storage Disease (LSD) by Type (2025-2030)
11.1.2 Global Lysosomal Storage Disease (LSD) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lysosomal Storage Disease (LSD) by Type (2025-2030)
11.2 Global Lysosomal Storage Disease (LSD) Market Forecast by Application (2025-2030)
11.2.1 Global Lysosomal Storage Disease (LSD) Sales (K Units) Forecast by Application
11.2.2 Global Lysosomal Storage Disease (LSD) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings